Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Novo Nordisk stock skidded Monday on reports an inspection turned up "objectionable conditions" at a diabetes and weight-loss drugs manufacturing plant.

Investors Business Daily

Wegovy: the slimming drug that keeps Denmark’s economy growing

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

The Guardian - UK

Dow Jones Futures Fall As Market Rally Nears Big Test; Meta Leads 4 Stocks Near Buy Points

The Nasdaq fell below its 50-day line with the market rally facing a big test. Meta is flirting with a buy point.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Ozempic, weight-loss ‘wonder drug’, under scrutiny amid suicide risk claims

Ozempic has not shown increased risk of suicidal ideation in trials, but some users say it harmed their mental health.

Al Jazeera

Wegovy has arrived in the UK: the story of the weight-loss jab so far

In February 2021, The Conversation reported on a trial for a new weight-loss drug, called semaglutide, that was being hailed in the media as a “gamechanger”. Gamechanger is a word used far too often by journalists to describe things that are, frankly, mundane. This time, though, the word seems apt.

The Conversation

Novo Nordisk beats LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug Wegovy to the U.K.

The Danish pharma giant overtook French luxury conglomerate LVMH as the most valuable European company, which held the title since 2021.

Fortune

Danish pharma group becomes Europe's most valuable firm after UK weight loss drug launch

Danish drugmaker Novo Nordisk is now Europe's largest company in market capitalisation, ahead of French luxury giant LVMH. This follows the UK launch of Wegovy, a weight loss drug that cuts appetite and cravings. Tens of thousands of people have already signed up to waiting lists for the treatment. Also…

France 24

Read news from The Economist, FT, and more,
with one subscription

Wegovy maker Novo Nordisk becomes Europe’s most valuable firm

Launch of weight-loss drug in UK helps Danish firm to market value of $428bn

The Guardian - UK

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

Ministers have announced plans which could see tens of thousands given access to new weight-loss drug

The Independent UK

Wegovy weight-loss jab to launch in the UK

The drug is in short supply but a proportion has been allocated to specialist NHS services

Evening Standard

The history of weight loss drugs

"It is no wonder demand for weight-loss drugs continues to soar"

Salon

Novo Nordisk: the pharma giant making Denmark rich from US obesity epidemic

Soaring demand for two weight-loss wonder-drugs developed by a Danish pharmaceutical company is having a knock-on effect on the whole of Denmark’s economy.

The Week

How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment

Novo Nordisk said Friday its obesity treatment, Wegovy, reduced heart-failure symptoms. But Novo Nordisk stock remained flat.

Investors Business Daily

Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly, Novo

Prescriptions of weight-loss and diabetes drugs have rocketed this year, giving Novo Nordisk stock and Eli Lilly stock more room to run.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Insulin Patients Can Find Discounts With Amazon's New Automated Coupon System

Amazon Pharmacy will automatically apply manufacturer-sponsored coupons for 15-plus products.

Fortune

A pharma company helping Elon Musk shed weight is now worth more than the entire economy of Denmark

The weight-loss and diabetes injectables have seen a surge in demand primarily in the U.S., buoying Novo Nordisk’s profits in the first half of 2023.

Investors Business Daily

Market Rally On The Ropes, AI Stocks Tumble: Weekly Review

The market rally suffered more damage as the Nasdaq undercut key support and many leading AI stocks sold off hard.

Investors Business Daily

Novo Reverses Obesity-Related Winning Streak, Diving On Light Sales

Novo is restricting some doses of Wegovy in the U.S., the company said Thursday. Novo Nordisk stock fell on light second-quarter sales.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Stocks higher, inflation data In focus, Disney earnings, Nvidia chip orders, Novo Nordisk Wegovy supplies - 5 Things To Know

Stock futures higher with inflation data in focus; Core inflation easing should offset headline CPI gain; Disney shares higher following mixed Q3 earnings, planned price hikes; Nvidia sees big AI chip orders from China and Novo Nordisk warns of Wegovy supply constraints in U.S. Markets.

Investors Business Daily

Is Eli Lilly Stock A Buy After FDA Pushes Back On Compounded Knockoffs?

Eli Lilly stock is trending lower in December, but an FDA decision will keep compounders from making tirzepatide. Is Lilly stock a buy?

The Independent UK

Weight-loss jabs can cut risk of heart attacks or strokes

Risk of heart attack or stroke cut by fifth, researchers say

Investors Business Daily

Dow Jones Futures Rise After Market Rally Holds Support; Two Big AI Losers

The market rally faces a key test. Nvidia is holding strong, but some Magnificent 7 stocks are ailing. Two AI plays dived late.

Kiplinger

Stock Market Today: Stocks Drop on Troubling China Data, Bank Ratings Worries

The main benchmarks fell Tuesday, but healthcare stocks outperformed as Eli Lilly and Novo Nordisk surged.

The Conversation

Ozempic is in the spotlight but it's just the latest in a long and strange history of weight-loss drugs

Losing weight conveniently, cheaply, safely. That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.

Fortune

The drug “has the potential to change how obesity is regarded and treated,” the company's executive vice president for development says.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations